Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets.
about
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failureLinking gene expression and functional network data in human heart failureArray data extractor (ADE): a LabVIEW program to extract and merge gene array data.Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies.Inhibition of new vessel growth in mouse model of laser-induced choroidal neovascularization by adiponectin peptide II.Identification of gene co-regulatory modules and associated cis-elements involved in degenerative heart diseaseLayered functional network analysis of gene expression in human heart failureDynamic functional modules in co-expressed protein interaction networks of dilated cardiomyopathy.Simvastatin inhibits cytokine-stimulated Cyr61 expression in osteoblastic cells: a therapeutic benefit for arthritis.cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1.A novel transmission-based test of association for multivariate phenotypes: an application to systolic and diastolic blood pressure levels.Matricellular proteins in cardiac adaptation and disease.Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model.Adiponectin as an anti-inflammatory factor.Molecular risk stratification in advanced heart failure patients.Genomics, transcriptional profiling, and heart failure.Methods to increase reproducibility in differential gene expression via meta-analysis.Potential of adiponectin as a cardioprotective agent.Revisited and revised: is RhoA always a villain in cardiac pathophysiology?Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs.Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature.A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression.Absent MicroRNAs in Different Tissues of Patients with Acquired CardiomyopathyIn silico pathway analysis: the final frontier towards completely rational drug design.Improved diagnosis of idiopathic giant cell myocarditis and cardiac sarcoidosis by myocardial gene expression profiling.Gene expression profiling: time to file diagnostic uncertainty in inflammatory heart diseases?Genomic analysis reveals poor separation of human cardiomyopathies of ischemic and nonischemic etiologies.Cardiac Remodeling: Endothelial Cells Have More to Say Than Just NO.
P2860
Q27691424-B143D3FD-BD7D-449D-9182-76BEB406B943Q28471842-D726B255-3F9E-42C3-A922-5A4C4706D78EQ30704168-A128F13F-397F-401F-83C5-D1500CDCC672Q33314619-5339D9D2-2D4F-4826-B245-65675CE3E64CQ33440992-9AE11FA7-ADA3-4B27-96CA-9A1AC0B664A3Q33454995-843F69EA-3498-4232-86A1-926C27B104B5Q33486544-BF920077-ABC3-4117-AE24-4E46A569AAFEQ33719832-4E1303AE-4ED1-451B-B87A-C31758F33535Q34101296-49DDF6E5-973B-4F6F-BB1D-F7ECE37F639FQ35033109-1F27200B-DC8B-4828-A5F0-803E7D828778Q35528141-6AC1AFC3-3333-48FB-B91B-932C08C6BC25Q35542423-70BFB99E-E08D-4E12-AD8E-E7F53E8CB377Q36510256-F2C1C0F6-A476-4EEF-9AF4-0507422B6140Q36753830-D8F7B40A-A604-4AE2-A902-3A6EF39D3B84Q37310977-13D30543-BE12-491B-B2F4-677680E2F3EEQ37473789-E68CA9D1-A6D6-424C-B495-726089CA5321Q37577407-36467F00-9E84-444F-9943-6E7419350614Q37608586-E2369BD7-535F-42D4-A3EB-FA7D49417A8AQ37766125-1B2C8C50-F2A6-4915-BED5-1B67DCDCB350Q37950457-AD41A1B6-777F-457F-BCDD-CE57145D2045Q38810914-031202E6-FFA3-49C4-B51C-1FCBF335E067Q39369050-E8B2C454-5B96-4204-97F9-A5F8915EF8F7Q39542328-20E6A966-6580-405E-9306-3DF50391343FQ40064969-F98FCF05-3C45-4249-927B-7B296258F850Q45750219-3314567B-1169-4360-859D-30A12471604CQ48542513-ABE02292-4BC9-47A8-931F-A64F60AD2084Q51887932-060E0D61-E24C-4609-A6D9-03085FEDEBDBQ55294487-BF372221-665F-4E81-96A4-B8075A94245A
P2860
Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Genomic expression profiling o ...... sts novel therapeutic targets.
@en
type
label
Genomic expression profiling o ...... sts novel therapeutic targets.
@en
prefLabel
Genomic expression profiling o ...... sts novel therapeutic targets.
@en
P2093
P2860
P1476
Genomic expression profiling o ...... ests novel therapeutic targets
@en
P2093
F Wittchen
H-P Schultheiss
M Pauschinger
P2860
P2888
P304
P356
10.1007/S00109-006-0122-9
P50
P577
2006-11-15T00:00:00Z